2009

• 20Oct
  Tuesday, October 20, 2009 ¬ 17:40:20
  NexMed Confirms NASDAQ Hearing Date
• 14Oct
  Wednesday, October 14, 2009 ¬ 17:40:20
  NexMed Provides Update on Anti-Fungal Product
• 27Aug
  Thursday, August 27, 2009¬ 17:40:20
  NexMed Submits Compliance Plan to NASDAQ
• 14Aug
  Friday, August 14, 2009¬ 17:40:20
  NexMed Receives NASDAQ Delisting Warning Letter
• 07Aug
  Friday, August 07, 2009¬ 17:40:20
  NexMed Announces Second Quarter 2009 Financial Results Conference Call
• 07Jul
  Tuesday, July 07, 2009¬ 17:40:20
  NexMed Announces Decision for Anti-Fungal Product
• 11May
  Monday, May 11, 2009¬ 17:40:20
  NexMed Reports First Quarter 2009 Financial and Operational Results
• 14Apr
  Tuesday, April 14, 2009¬ 17:40:20
  NexMed Engages FTN Equity Capital Markets Corp.
• 24Mar
  Tuesday, March 24, 2009¬ 17:40:20
  NexMed Receives NASDAQ Delisting Warning Letter
• 16Mar
  Monday, March 16, 2009¬ 17:40:20
  NexMed Reports 2008 Year End Financial and Operational Results
• 06Mar
  Friday, March 6, 2009¬ 17:40:20
  NexMed Announces Presentation of Data at the 67th Annual Meeting of the American Academy of Dermatology
• 03Feb
  Tuesday, February 03, 2009¬ 17:40:20
  NexMed to Present at the 11th Annual BIO CEO & Investor Conference
• 03Feb
  Tuesday, February 03, 2009¬ 17:40:20
  NexMed Announces Sale of U.S. Rights for Topical Erectile Dysfunction Treatment
• 22Jan
  Thursday, January 22, 2009¬ 17:40:20
  PII and NexMed Enter Into Strategic Collaboration Agreement for NexMed's NexACT^® drug delivery Platform